Fundraising FoxAthos Therapeutics
Torrance, US · Founded 2019 · Delaware corporation
Find your way into Athos Therapeutics
Sign up to see every warm intro you have to Athos Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Athos Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Athos Therapeutics was founded in 2019 by Dimitrios Iliopoulos.
DI
Dimitrios IliopoulosFounder
AJ
Allan J. PantuckNamed on SEC filing
Board
CM
Carl McKinzieBoard director
LS
Laurence SteinBoard director
JC
Joel CohenBoard director
AZ
Anthony ZingaleBoard director
Reported raises · per SEC filings
Form D private placements$38.3M disclosed across 3 rounds · 2021–2026
▶$10.3MraisedMay 2026 · 40 investors · PharmaceuticalsRule 506(b)
▶$10.3MraisedMay 2026 · 40 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Carl McKinzieDirector
- Laurence SteinDirector
- Joel CohenDirector
- Anthony ZingaleDirector
- Dimitrios IliopoulosExecutive Officer, Director
- Allan J. PantuckExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $10.3M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.6MraisedFeb 2024 · 30 investors · PharmaceuticalsRule 506(b)
▶$7.6MraisedFeb 2024 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Anthony ZingaleDirector
- Joel CohenDirector
- Allan J. PantuckExecutive Officer, Director
- Carl McKinzieDirector
- Dimitrios IliopoulosExecutive Officer, Director
- Offering amount
- $35M
- Amount sold
- $7.6M
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$20.4MraisedNov 2021 · 103 investors · PharmaceuticalsRule 506(b)
▶$20.4MraisedNov 2021 · 103 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dimitrios IliopoulosExecutive Officer, Director
- Joel CohenDirector
- Allan J. PantuckExecutive Officer, Director
- Carl McKinzieDirector
- Offering amount
- $20.4M
- Amount sold
- $20.4M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Athos Therapeutics?
- Athos Therapeutics was founded by Dimitrios Iliopoulos in 2019.
- How much funding has Athos Therapeutics raised?
- Athos Therapeutics has disclosed $38.3M raised across 3 rounds.
- Where is Athos Therapeutics headquartered?
- Athos Therapeutics is headquartered in Torrance, US.